Several independent groups have undertaken RNA profile analysis of primary human breast cancers and mouse models of PIK3CA mutant ER+ breast cancer and uncovered AKT-independent downstream signaling events that contribute to tumor progression [25,96,99]. Here, PIK3CA is linked to breast carcinoma.